Development and Psychometric Properties of the Human Papillomavirus‐Know Questionnaire ( HPV ‐Know‐Q) to Assess the Knowledge of Women on HPV Infection and Related Outcomes
Journal of Obstetrics and Gynaecology Research · 2026
DOI: 10.1111/jog.70154 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Carmen González-Granados und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Hospital Quirónsalud, Málaga, Spain. Hauptthemen laut MEDLINE: Psychometrics, Papillomavirus Infections, Health Knowledge, Attitudes, Practice, Patient Reported Outcome Measures. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Aim
To provide the psychometric properties of a novel patient‐reported outcomes measurement (PROM), the HPV‐Know‐Q questionnaire, to assess the HPV‐related knowledge in adult women in Spain.
Methods
After reviewing literature and interviewing women with HPV infection, instrument items and domains were developed. A draft self‐administered, multiple‐choice questionnaire including relevant questions about HPV infection was pilot tested for comprehension and ease of completion. Psychometric evaluation of the final HPV‐Know‐Q questionnaire was performed in a cross‐sectional, multicenter, validation study conducted in a representative sample of women with HPV infection attending gynecology consultations in Spain.
Results
A total of 349 (153 HPV+/196 HPV−) women participated. HPV‐Know‐Q questionnaire had acceptable metric properties of feasibility, internal consistency and temporal stability (reliability). Construct validity was supported by analyzing item‐to‐item and item‐to‐domain correlation and know groups validity, which discriminated the knowledge on HPV of women related to their infection status, abnormal cytology, educational level and prior HPV vaccination. Concurrent validity was demonstrated with a significant correlation with other scales measuring mental and sexual functioning.
Conclusion
The HPV‐Know‐Q questionnaire, a novel and innovative PROM, showed acceptable psychometric properties to evaluate the HPV knowledge in women that support its use in daily medical practice and research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Hospital Quirónsalud, Málaga, Spain.
- EACCOS Research Group, Universidad Autónoma de Madrid, Madrid, Spain.
- Women Health Institute, Hospital Clínico San Carlos, IdISSC School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
- Corofas Menopause Unit, Hospital Sanitas la Zarzuela, Universidad Francisco de Vitoria, Madrid, Spain.
ORCID-Profile: Javier Calvo-Torres, María Fasero
Zitieren
APA
González-Granados, C., Rejas-Gutiérrez, J., Calvo-Torres, J., Ramírez-Mena, M., García-Santos, J. F., Bellón, M., Fasero, M., & Coronado, P. J. (2026). Development and Psychometric Properties of the Human Papillomavirus‐Know Questionnaire ( HPV ‐Know‐Q) to Assess the Knowledge of Women on HPV Infection and Related Outcomes. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70154
Vancouver
González-Granados C, Rejas-Gutiérrez J, Calvo-Torres J, Ramírez-Mena M, García-Santos JF, Bellón M, et al. Development and Psychometric Properties of the Human Papillomavirus‐Know Questionnaire ( HPV ‐Know‐Q) to Assess the Knowledge of Women on HPV Infection and Related Outcomes. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70154
BibTeX
@article{GonzlezGranados2026,
author = {González-Granados, Carmen and Rejas-Gutiérrez, Javier and Calvo-Torres, Javier and Ramírez-Mena, Mar and García-Santos, Javier F and Bellón, Mónica and Fasero, María and Coronado, Pluvio J},
title = {Development and Psychometric Properties of the Human Papillomavirus‐Know Questionnaire ( HPV ‐Know‐Q) to Assess the Knowledge of Women on HPV Infection and Related Outcomes},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
doi = {10.1111/jog.70154}
}
EUVIMED